Company Filing History:
Years Active: 2004-2010
Title: The Innovative Contributions of Rosalyn B. Irby
Introduction
Rosalyn B. Irby is a prominent inventor based in Tampa, FL (US). She has made significant contributions to the field of biotechnology, particularly in the area of oncogenes. With a total of 3 patents to her name, her work has implications for research, diagnostics, and clinical applications.
Latest Patents
One of her latest patents is titled "Mutated Src oncogene composition and methods." This invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. The patent outlines methods for isolating, expressing, and characterizing recombinant Src mutant polypeptides. Furthermore, it relates to the utilization of such oligonucleotides, polypeptides, agonists, and antagonists for various applications in research, diagnostics, and clinical arts. More specifically, this invention offers methods for diagnosing, treating, immunizing, and creating transgenic animals based on the use of the mutant Src.
Career Highlights
Rosalyn B. Irby is affiliated with the University of South Florida, where she continues her research and innovation in biotechnology. Her work has garnered attention for its potential to advance medical science and improve patient outcomes.
Collaborations
One of her notable collaborators is Timothy J. Yeatman, with whom she has worked on various projects related to her patents and research initiatives.
Conclusion
Rosalyn B. Irby exemplifies the spirit of innovation in the field of biotechnology. Her contributions, particularly in the area of oncogenes, have the potential to make a lasting impact on medical research and treatment methodologies.